Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Paired-Like Homeodomain 1 (PITX1) Peptide

PITX1 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN981796

Aperçu rapide pour Paired-Like Homeodomain 1 (PITX1) Peptide (ABIN981796)

Antigène

PITX1 (Paired-Like Homeodomain 1 (PITX1))

Origine

Humain

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-PITX1 antibody (Catalog #: ARP38176_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    PITX1 (Paired-Like Homeodomain 1 (PITX1))

    Sujet

    PITX1 is a member of the RIEG/PITX homeobox family, which is involved in organ development and left-right asymmetry. This protein acts as a transcriptional regulator involved in basal and hormone-regulated activity of prolactin.

    Alias Symbols: BFT, CCF, POTX, PTX1

    Protein Interaction Partner: RASAL1,DVL3,EGR1,NEUROD1,NR5A1,POU1F1,RBPMS,RHOXF2,DVL3,EGR1,NR5A1,POU1F1,RBPMS,RHOXF2

    Protein Size: 314

    Poids moléculaire

    34 kDa

    ID gène

    5307

    NCBI Accession

    NM_002653, NP_002644

    UniProt

    P78337
Vous êtes ici:
Chat with us!